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Abstract 
Dietary omega-3 polyunsaturated fatty acids (PUFAs) are readily incorporated into heart and skeletal 
muscle membranes where, in the heart, animal studies show they reduce O2 consumption. To test the 
hypothesis that omega-3 PUFAs alter O2 efficiency in humans, the effects of fish oil (FO) supplementation 
on O2 consumption during exercise were evaluated. Sixteen well-trained men (cyclists), randomly 
assigned to receive 8 x 1 g capsules per day of olive oil (control) or FO for 8 weeks in a double-blind, 
parallel design, completed the study (control: n = 7, age 27.1 +/- 2.7 years; FO: n = 9, age 23.2 +/- 1.2 
years). Subjects used an electronically braked cycle ergometer to complete peak O2 consumption tests 
(VO2peak) and sustained submaximal exercise tests at 55% of peak workload (from the VO2peak test) 
before and after supplementation. Whole-body O2 consumption and indirect measurements of 
myocardial O2 consumption [heart rate and rate pressure product (RPP)] were assessed. FO 
supplementation increased omega-3 PUFA content of erythrocyte cell membranes. There were no 
differences in VO2peak (mL kg-1 min-1) (control: pre 66.8 +/- 2.4, post 67.2 +/- 2.3; FO: pre 68.3 +/- 1.4, 
post 67.2 +/- 1.2) or peak workload after supplementation. The FO supplementation lowered heart rate 
(including peak heart rate) during incremental workloads to exhaustion (P < 0.05). In addition, the FO 
supplementation lowered steady-state submaximal exercise heart rate, whole-body O2 consumption, and 
RPP (P < 0.01). Time to voluntary fatigue was not altered by FO supplementation. This study indicates 
that FOs may act within the healthy heart and skeletal muscle to reduce both whole-body and myocardial 
O2 demand during exercise, without a decrement in performance. 
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ABSTRACT 
Dietary omega-3 polyunsaturated fatty acids (PUFA) are readily incorporated into heart and skeletal 
muscle membranes where, in the heart, animal studies show they reduce O2 consumption. To test 
the hypothesis that omega-3 PUFA alter O2 efficiency in humans, the effects of fish oil 
supplementation on O2 consumption during exercise were evaluated. Sixteen well-trained men 
(cyclists), randomly assigned to receive 8x1g capsules per day of olive oil (control) or fish oil (FO) for 
8 weeks in a double blind parallel design, completed the study (control n=7, age 27.1±2.7y; FO n=9, 
age 23.2±1.2y). Subjects used an electronically braked cycle ergometer to complete peak O2 
consumption tests (VO2peak) and sustained submaximal exercise tests at 55% of peak workload 
(from the VO2peak test), before and after supplementation. Whole body O2 consumption and indirect 
measurements of myocardial O2 consumption (heart rate and rate pressure product) were assessed. 
FO supplementation increased omega-3 PUFA content of erythrocyte cell membranes. There were 
no differences in VO2peak (ml/kg/min) (control: pre; 66.8±2.4 post; 67.2±2.3 : FO: pre; 68.3±1.4 post; 
67.2±1.2) or peak workload following supplementation. The FO supplementation lowered heart rate 
(including peak heart rate) during incremental workloads to exhaustion (p<0.05). In addition, the FO 
supplementation lowered steady state submaximal exercise heart rate, whole body O2 consumption 
and rate pressure product (p<0.01). Time to voluntary fatigue was not altered by fish oil 
supplementation. This study indicates that fish oils may act within the healthy heart and skeletal 
muscle to reduce both whole body and myocardial O2 demand during exercise, without a decrement 
in performance. 
 
Key words: fish oil, heart rate, rate pressure product, oxygen consumption, exercise. 
 
INTRODUCTION 
Dietary fish oil supplementation alters myocardial membrane fatty acid composition 1,2 and modifies 
heart function in animals, providing direct antiarrhythmic effects 2-4 and improved pumping 
performance 5,6. In addition, fish oil reduces myocardial O2 consumption without any decrement in 
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cardiac work, indicating an increase in cardiac energy efficiency 6. In humans the direct effects of 
dietary fish oil in the myocardium prevent fatal arrhythmia 7,8, and reduce resting heart rate 9,10. A 
small but consistent reduction in heart rate has recently been distilled from many clinical trials 
through meta-analysis 11 and indirectly supports the notion that myocardial oxygen consumption is 
decreased when fish is present in the diet. In view of the influential role of long chain omega-3 
PUFA, found primarily in marine oils, in modifying cardiac function in disease states and preventing 
or treating cardiovascular disease, it is likely that they may play an important role in the healthy 
heart, including modifying myocardial O2 demand during aerobic exercise.  
 
Erythrocyte membrane content of the omega-3 polyunsaturated fatty acids (PUFA) eicosapentaenoic 
acid (EPA) + docosahexaenoic acid (DHA) is a known marker as a risk factor for cardiovascular 
disease being reflective of myocardial membrane composition 12,13. Dietary fats are also reflected in 
skeletal muscle membrane fatty acid composition 1,14,15. Compared to many other organs, both heart 
and skeletal muscle membranes incorporate high levels of DHA with fish oil feeding 1,15. Increased 
DHA levels in skeletal muscle membrane modifies muscle function, increasing insulin sensitivity 16 
and possibly substrate preference 17. To our knowledge, there has been no published work that 
investigates if changes in membrane fatty acid composition are associated with altered skeletal 
muscle O2 consumption as previously seen in the heart 
6.  
 
It was the premise of this study that dietary fish oil may have direct effects on human heart function 
in well trained males to enhance cardiac energy efficiency during exercise and in addition, possibly 
enhance efficiency of oxygen use in exercising skeletal muscle.  
 
SUBJECTS AND METHODS 
Twenty, healthy well-trained male cyclists were recruited and sixteen completed the dietary trial. Two 
subjects were eliminated from the study when their training patterns changed during the study and 
two subjects withdrew due to injury unrelated to the study. Cyclists were the subjects of choice due 
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to their extended periods of steady state training and the specificity of the cycle ergometer to this 
population. Furthermore, the highly trained characteristics of this group ensured central 
cardiovascular limitation rather than peripheral muscular fatigue during peak O2 consumption testing. 
The study was approved by the University of Wollongong, Human Research Ethics Committee. All 
subjects completed an informed consent. 
 
Study Design 
Subjects were randomly allocated, in a double blind manner to two groups and supplemented with 8 
× 1g capsules per day of either olive oil (control) or omega-3 PUFA-rich tuna fish oil (FO) (Numega, 
Clover Corporation, Sydney, Australia) for 8 weeks. Some anthropometric characteristics of those 
completing the trial were: Control age: 27.1±2.7y; height: 177.3±1.3cm; weight: 75.2±2.9kg; skinfolds 
(sum of 7): 45.1±1.4mm or FO age: 23.2±1.2y; height: 176.5±1.6cm; weight: 69.3±1.9kg; skinfolds: 
51.8±2.3mm. The relative composition of fatty acids in the capsules was quantified using gas 
chromatography (Table 1). For the FO group this provided 3.2g of omega-3 PUFA per day (0.8g of 
eicosapentaenoic acid (EPA) and 2.4g of docosahexaenoic acid (DHA)). Compliance was verified 
through capsule count and red blood cell fatty acid analysis.  
[Table 1. near here] 
 
To limit influences of training variation, dietary supplementation and testing took place during a non-
competitive period of the Australian cycle calendar. All subjects were asked to provide records of 
their training, specifically their resting morning heart rate and the duration, in minutes, spent at 
particular training heart rates (as indicated by their personal heart rate monitors). A mean weekly 
training impulse representing intensity and duration of training, was calculated according to the 
following formula 18. 
 
Training Impulse = Duration (min) x (HRex – HRrest) / (HRmax – HRrest) 
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Where: Duration = Time spent in steady state exercise; HRex = Exercise heart rate during training; 
HRrest = Resting heart rate; HRmax = Maximum heart rate recorded in the laboratory. 
 
Peak O2 consumption tests were conducted prior to and after 8 weeks of supplementation, each 
followed by a sustained submaximal cycling test to exhaustion one week later. Subjects refrained 
from high intensity cycling for 48h prior to testing. They were instructed to arrive at the laboratory on 
each testing day in a euhydrated (20mL fluid/kg body weight) and fed state (2g carbohydrates/kg 
body weight). Environmental room conditions were maintained at 18-200 C and 45-55% relative 
humidity.  
 
An electronically braked cycle ergometer (Lode Ergo, Netherlands) was used for exercise testing. 
Heart rate was recorded using a heart rate monitor (Polar, NY, USA). Respiratory data was collected 
using the Sensor Medics Gas Analysis System (2900c) (Sensor Medics Corporation, CA, USA) over 
a 20s rolling average. Ratings of perceived exertion were made using the 15-point Borg scale 19. 
Systolic blood pressure was recorded using the automatic oscillometric DinamapTM Vital Signs 
Monitor (Johnson and Johnson Pty Ltd, North Ryde, Sydney). To reduce operator error, all 
measurements of blood pressure during exercise were taken on the subject’s left arm, by the same 
person. Subjects were asked to relax the arm in a vertical plane next to their body.  
 
Peak oxygen consumption test  
Subjects commenced with a 10min warm up period at a workload of 150 watts. The workload was 
incremented by 2 watts every 3s until a workload was reached at which the subject could not 
maintain a peddling cadence greater than or equal to 40rpm. This point was defined as voluntary 
exhaustion. Peak O2 consumption, peak workload, submaximal heart rates and peak heart rate, and 
submaximal ratings of whole body perceived exertion were assessed. Blood pressure was not 
recorded during this test due to the demanding nature of the exercise and the likely interference with 
performance. The peak O2 consumption test was repeated after dietary supplementation. 
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Submaximal cycling test  
Workload for the submaximal exercise test was set at 55% of the peak workload derived from the 
pre-supplementation peak O2 consumption test. This same absolute workload was used following 
supplementation, allowing a direct comparison to be made for pre to post-supplementation 
measurements of whole body O2 consumption, heart rate and systolic blood pressure. Subjects were 
instructed to continue to cycle until voluntary exhaustion. Pilot testing in our laboratory indicated that 
this level of steady state work could be maintained for at least 60min, thus ensuring that all tests 
represented prolonged steady state exercise. Subjects consumed water ad lib, throughout the tests 
and cycled to voluntary exhaustion. 
 
All data were collected for the first 60min of submaximal exercise and during the final minutes before 
voluntary exhaustion. Heart rate was collected continuously (averaged over 5s). Systolic blood 
pressure, respiratory data and ratings of perceived exertion were taken every 10min and the rate 
pressure product (RPP) (product of the systolic blood pressure and heart rate) calculated.  
 
Fatty acid analysis  
Omega-3 PUFA level in red blood cell membranes was used as a marker of general tissue omega-3 
PUFA uptake following dietary supplementation 12,13,20. Prior to and following supplementation, blood 
samples were collected from the median cubital vein into EDTA and stored on ice until separation. 
Cells were sedimented by centrifugation at 40C, plasma was removed and frozen, buffy coat was 
removed and the red blood cells stored at –800C. 
 
For analysis, red blood cells were thawed on ice, lysed in 10mL of Tris-buffer (10mM, pH=7.4), 
centrifuged at 40C to separate red cell membranes. Membranes fatty acids were directly 
transesterified to produce methyl esters 21. The relative proportions of fatty acids incorporated into 
the red blood cell membranes were analysed by flame ionization gas chromatography (Shimadzu 
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GC-17A, 30m x 0.25mm internal diameter capillary column). Fatty acids were identified by 
comparison with known standards and reported as relative percent by weight.  
 
Statistical analysis  
Values are presented as mean ± SEM. A two-way analysis of variance (ANOVA) with repeated 
measures was used to detect significance between groups over time pre and post supplementation 
and within groups as an effect of supplementation. Differences between individual means, within and 
between dietary groups was further analysed by post-hoc Bonferroni analysis. Statistical significance 
was accepted at p<0.05 level. Statistical analysis was performed using Statistix for Windows 
(Analytical Software, Tallahassee, Florida, USA). 
 
RESULTS 
Subjects  
There was no significant difference in fish consumption between the groups prior to dietary 
supplementation (Control: 3.3±0.3; FO: 2.8±0.3 fish meals per month). The mean training impulse 
(TI) per week was consistent within groups during the 8 weeks supplementation (data not shown) 
and there was no significant difference between dietary groups (Control: 512±26; FO: 462±99 
TI/week). 
 
Red blood cell membrane fatty acids  
There were no significant differences in red blood cell fatty acid composition prior to 
supplementation. There were no changes in fatty acid composition after control supplementation. 
Following FO supplementation there were significant increases in membrane fatty acid levels of DHA 
(22:6n-3), the sum of PUFA and the sum of omega-3 PUFA (p<0.05) (Table 2). The FO 
supplementation produced no change in the polyunsaturated/saturated (P:S) ratio (Control pre: 1.05; 
post: 1.06; FO pre: 1.02; post 1.07) but significantly decreased the (n-6)/(n-3) ratio (Control pre: 
1.48; post: 1.44; FO pre: 1.6; post 1.17) (p<0.05). 
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[Table 2. near here] 
 
Peak Oxygen Consumption Test 
There were no differences in peak O2 consumption or peak workload between groups prior to or after 
supplementation or within groups after supplementation (Table 3). Heart rate increased with 
increasing workload during the test. There was no significant difference in peak heart rate between 
control and FO groups prior to supplementation (Table 3). The heart rate response during increasing 
workload was not different after control supplementation, however after the FO supplementation the 
heart rate was significantly lower during increasing workload (p<0.001) and a significant decrease in 
peak heart rate was seen within the FO group following supplementation (p<0.05) (Figure 1). 
Supplementation had no effect on ratings of perceived exertion (legs, chest, whole body), reported at 
four sub-maximal workloads (data not shown). 
[Table 3. near here] [Figure 1. near here] 
 
Submaximal cycling test 
There was no significant difference during the first 60min of the test in mean whole-body 
submaximal O2 consumption between groups prior to supplementation (Control Pre: 49.2±2.0; FO 
Pre: 51.1±1.1 ml/kg/min). Whole body O2 consumption in the control group was not significantly 
different after supplementation. Whole body O2 consumption during exercise was reduced in the FO 
group and the change was significantly different to the control group (p<0.01) (Figure 2). There was 
no significant difference in mean respiratory exchange ratio between groups prior to 
supplementation or within groups after supplementation (Control Pre: 0.91±0.02; Post: 0.91±0.03; 
FO Pre: 0.92±0.02; Post: 0.92±0.03).  
[Figure 2. near here] 
 
The FO group had significantly lower heart rate throughout sustained submaximal exercise (p<0.01) 
after supplementation compared with before (Figure 3). This reduction was such that the mean heart 
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rate of the FO group over the entire exercise period was significantly lower than the control group 
after supplementation (p<0.05) (Table 4). Systolic blood pressure showed no significant change with 
supplementation (data not shown).  
[Figure 3. near here] [Table 4. near here] 
 
The rate pressure product (heart rate x systolic blood pressure) during the first 60min of sustained 
submaximal exercise and the mean of the entire submaximal exercise trial were significantly lower 
after FO supplementation (Figure 4) and the mean change over time was significantly different to the 
control group (p<0.01) (Figure 4). Table 4 shows absolute rate pressure products. The FO group 
approached significantly lower absolute values compared to the controls after supplementation 
(p=0.08). There were no differences between groups in time to fatigue before or after 
supplementation and no significant differences after supplementation within groups (Table 4) 
[Figure 4. near here] 
 
Ratings of perceived exertion (legs, chest, whole body) were significantly higher in the fish oil group 
prior to supplementation but were not significantly different afterwards. Both groups reported 
changes in RPE, however, within the FO group there were significantly larger RPE changes reported 
overtime for chest and whole body (p<0.01) and this approached significance for legs (p=0.07) (data 
not shown).  
 
DISCUSSION 
After dietary fish oil supplementation, already well-trained athletes exhibited lower heart rates 
throughout exercise across a wide range of workloads, with no change in peak oxygen consumption 
or peak workload. The heart rate, rate pressure product and whole body O2 consumption were also 
reduced throughout 60min of sustained submaximal exercise after FO supplementation. Thus, the 
present study indicates that efficiency of O2 use by the heart and skeletal muscle is increased after 
fish oil supplementation in humans as it is in rat hearts 6,22.  
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Dietary supplementation with fish oil increased the incorporation of omega-3 PUFA into red blood 
cells to a level exceeding that observed with long term habitual intake of 0.5g per day 23. Such 
habitual intake and accompanying red cell omega-3 PUFA levels are associated with reduced 
relative risk of primary (arrhythmic) cardiac arrest. The antiarrhythmic effects of fish oil have been 
linked to direct effects in the heart 2,4,24,25 dependent on myocardial membrane incorporation of 
omega-3 fatty acids, especially DHA. Myocardial membrane omega-3 PUFA composition is strongly 
associated with red cell membrane composition in both humans and animals 12,13,15. Myocardial cells 
incorporate higher levels of omega-3 fatty acids than do red blood cells 15,24 or serum phospholipids 
26. Thus, the increase in red blood cell incorporation in cyclists not only confirmed compliance to the 
supplementation regimen but may be indicative of even greater incorporation into skeletal muscle 
and myocardial membranes. Human skeletal muscle incorporates increased omega-3 PUFA with 
fish oil consumption 27 and several studies have shown that physical training itself is associated with 
increased human skeletal muscle omega-3 PUFA content independent of diet 28,29. The DHA content 
correlates with the muscle content of type I, slow oxidative fibres 29 which are more efficient in their 
use of oxygen, fatigue resistant and display higher insulin sensitivity 28,29. The hypothesis that fish oil 
supplementation could lead to altered cardiac or skeletal muscle energy efficiency was dependent 
upon changes occurring in their membrane omega-3 PUFA composition. The observed changes in 
red blood cell membrane composition suggest that such changes were achieved. Importantly, in all 
of these young well-trained subjects, whether supplemented with fish oil or not, the erythrocyte 
omega-3 index (sum of EPA + DHA) was above the low levels proposed to represent heightened risk 
of cardiac disease and above the minimum levels associated with cardio-protection 12,13. 
 
Previously a study reported that peak O2 consumption was increased following fish oil feeding 
30. 
The results of the current investigation do not concur with this finding. In fact, no change in peak O2 
consumption is consistent with two later studies also showing effect of fish oil supplementation 31,32. 
Importantly, the present investigation used cyclists during a controlled stage of their training season, 
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with peak O2 consumption indicative of well-trained individuals 
33. This reduced the possibility of 
changes in peak O2 consumption occurring as an artifact of training, which could not be ruled out in 
the earliest study 30. Furthermore, all subjects in the present investigation were familiar with and 
highly competent in using the cycle ergometer, as the testing modality, unlike the soccer players in 
an earlier investigation 32.  
 
Fish oil supplementation reduces resting heart rate in man 11 not unlike the low resting 34 and 
exercising heart rates 35 associated with regular physical training. While higher parasympathetic 
activity is in part responsible for the lower resting heart rates of trained athletes 34, intrinsic beat rate 
may also be reduced, which may be attributable to altered myocardial cell metabolism leading to 
more efficient energy generation or utilization 35. Studies of the isolated spontaneously beating heart 
show that fish oil can indeed reduce intrinsic heart rate 2 and increase cardiac energy efficiency 
when the heart is paced at a constant rate 6. Skeletal muscle cellular metabolism is also altered with 
exercise 36. In man, myocardial O2 consumption correlates strongly with heart rate but most strongly 
with the product of heart rate and aortic systolic pressure (also termed the index of cardiac effort) 37. 
In fish oil supplemented subjects, the lower heart rate and rate pressure product observed 
throughout both peak and submaximal exercise in this study suggest that myocardial O2 
consumption was reduced.  
 
An additional, often small but consistent effect of fish oil is to reduce resting heart rate, in man 38 and 
in rats 5,39. Regular fish consumption or erythrocyte DHA levels indicative of fish intake were 
associated with slowed heart rate at rest in a large epidemiological study of untrained adult males 9 
and in both stand alone studies 10,40 and distilled meta-analysis of randomised controlled dietary 
supplementation trials 11. In addition, heart rate is reduced in association with omega-3 PUFA 
supplementation not only in rat isolated spontaneously beating hearts 2, but also in cardiac 
transplant patients in the absence of vagal tone, which excludes a neurogenic mechanism 41. 
Furthermore, reduction in post-exercise recovery heart rate in this patient group is also improved 
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following fish oil supplementation 42. The reduction in heart rate during exercise has been found in 
trained horses across a range of treadmill speeds 43 in a manner very similar to the present study 
using trained cyclists. A slowed heart rate and associated prolonged cardiac diastole would provide 
more time per minute for coronary artery perfusion and myocardial oxygenation. Moreover, with 
heart rate proposed as a risk factor for cardiovascular mortality 44, its association with risk of death or 
hospitalisation in heart failure patients 45  provides further links to omega-3 PUFA.  For in addition to 
reducing heart rate 11, fish oil supplementation reduces mortality in heart failure patients 46 and fish 
consumption is associated with lower primary incidence of heart failure 47. The slowed heart rate and 
improved oxygen efficiency together with the reduced exercise-induced muscle damage and 
inflammation associated with omega-3 PUFA 48 may also be important modulators of heart fatigue 
and even damage that is suggested to occur during extended exercise 49.  
 
The reduced whole body O2 consumption seen after fish oil supplementation may reflect reduced 
(more efficient) use of O2 by active skeletal muscle (the largest consumer of oxygen during 
exercise). Skeletal muscle shares the capacity of cardiac tissue to avidly incorporate omega-3 
PUFA, particularly DHA, well above circulating levels 1,15. In animals and man, unsaturation of 
skeletal muscle membrane increases insulin sensitivity 16,28,29 and results in an increased ability of 
skeletal muscle cells to take-up glucose, which might be expected to maintain contractile 
performance. Long chain omega-3 PUFA can also shift substrate preference to glucose in skeletal 
muscle 17 and since energy derived from the breakdown of 1 mole of glucose requires less O2 than 
the equivalent amount derived from fat 50, this may explain the reduced whole body O2 consumption. 
However, the unchanged respiratory exchange ratio is contradictory. Alternatively, fish oil has been 
shown to improve calcium handling in the heart and reduce O2 consumption attributed to excessive 
sarcoplasmic reticulum calcium cycling 6. The sarcoplasmic reticulum membrane also avidly 
incorporates DHA when fish oil is present in the diet 51. Human skeletal muscle has been calculated 
to use up to 37% of energy in the Ca++ cycling of activation and relaxation 52. Improved calcium 
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handling by skeletal muscle sarcoplasmic reticulum with fish oil supplementation could be a factor 
contributing to reduced O2 demand of contracting skeletal muscle as in the heart 
25. 
 
Despite requiring the subjects to cycle submaximally until voluntary fatigue, this study did not 
attempt to link fish oil supplementation to altered exercise performance. Time to fatigue as used in 
the present study carries a high degree of within-subject variability and therefore is considered a 
weak performance indicator 53 and a more suitable indicator such as the cycling time trial would be 
better indicator of fatigue during endurance performance 54,55. However, it is unlikely that the fish oil 
induced improved oxygen efficiency could lead to measurable improvement in endurance 
performance because this type of exercise is not entirely oxygen limited 56 and elite performance is 
multi-factorial in nature 57.  
 
Conclusion  
This study showed that supplementing healthy, well-trained male subjects with fish oil over 8 weeks, 
significantly lowered heart rate, rate pressure product and whole body O2 consumption during 
exercise. Importantly, the peak levels of whole body O2 consumption and workload were not 
influenced despite the reduced peak heart rate. These results confirmed that fish oil supplementation 
reduces myocardial O2 demand during exercise. Furthermore, there is evidence that skeletal muscle 
O2 consumption is also reduced following fish oil supplementation.  
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Legends to figures:  
Figure 1: Change in heart rate response for control (∆) and FO () groups during incrementing 
workloads to peak performance following 8 weeks dietary supplementation. * p<0.01. 2-way ANOVA. 
Mean ± SEM.  
 
Figure 2: Change in whole body O2 consumption within control (∆) and FO () groups during 
submaximal cycling test following 8 weeks dietary supplementation. Measurements are shown over 
the first hour of exercise (*p<0.01 2-way ANOVA), and as a mean value representing the 
submaximal cycling test (** p<0.05 1-way ANOVA). Mean Control (▲) and FO (). Mean ± SEM.  
 
Figure 3: Change in heart rate response for control (∆) and FO () groups during submaximal 
cycling test following 8 weeks dietary supplementation. Measurements are shown over the first hour 
of exercise (*p<0.01 2-way ANOVA), and as a mean value representing the submaximal cycling test 
(** p<0.05 1-way ANOVA). Mean Control (▲) and FO (). Mean ± SEM. 
  
Figure 4: Change in rate pressure product response for control (∆) and FO () groups during 
submaximal cycling test following 8 weeks dietary supplementation. Measurements are shown over 
the first hour of exercise (*p<0.05 2-way ANOVA), and as a mean value representing the 
submaximal cycling test (** p<0.05 1-way ANOVA). Mean Control (▲) and FO (). Mean ± SEM.  
 
